The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and synthesis of potent and selective BACE-1 inhibitors.EBI
Stockholm University
Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central core.EBI
Stockholm University
P2'-truncated BACE-1 inhibitors with a novel hydroxethylene-like core.EBI
Stockholm University
Fragment-Based Discovery of Subtype-Selective Adenosine Receptor Ligands from Homology Models.EBI
Stockholm University
Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitors.EBI
Stockholm University
Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space.EBI
Stockholm University
Prolyl hydroxylase inhibitorsBDB
Aerpio Therapeutics
Fumagillol heterocyclic compounds and methods of making and using sameBDB
Zafgen
Bisaryl-bonded aryltriazolones and use thereofBDB
Bayer Intellectual Property